SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024514
Filing Date
2021-05-06
Accepted
2021-05-06 07:15:36
Documents
73
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kymr-10q_20210331.htm 10-Q 2506243
2 EX-31.1 kymr-ex311_9.htm EX-31.1 19646
3 EX-31.2 kymr-ex312_8.htm EX-31.2 19599
4 EX-32.1 kymr-ex321_7.htm EX-32.1 9343
5 EX-32.2 kymr-ex322_6.htm EX-32.2 9337
  Complete submission text file 0001564590-21-024514.txt   8355192

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kymr-20210331.xml EX-101.INS 1711610
7 XBRL TAXONOMY EXTENSION SCHEMA kymr-20210331.xsd EX-101.SCH 62777
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kymr-20210331_cal.xml EX-101.CAL 56843
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kymr-20210331_def.xml EX-101.DEF 218583
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kymr-20210331_lab.xml EX-101.LAB 496593
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kymr-20210331_pre.xml EX-101.PRE 368424
Mailing Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39460 | Film No.: 21895772
SIC: 2836 Biological Products, (No Diagnostic Substances)